“…CE obviously allowed major implications for the diagnosis, therapeutic decision‐making, and outcomes in the management of obscure gastrointestinal (GI) bleeding . Recently, the availability of CE for other clinical conditions, including hereditary polyposis syndrome, malabsorption syndrome, and inflammatory bowel diseases, have been increasingly reported. In Crohn's disease (CD), a growing body of evidence shows a favorable diagnostic yield of CE ranging between 58% and 71%, and a recent meta‐analysis confirmed significantly higher diagnostic yields of CE when compared with small bowel radiography, computed tomography (CT) enterography, or magnetic resonance enterography .…”